With an eye toward advancing clinical quality and operational excellence, Texas Health Resources has named Daniel Varga, M.D., as chief clinical officer and senior executive vice president. He’ll assume his new post on Jan. 14.
Varga comes to THR from KentuckyOne, the largest health system in Kentucky, where he served as chief clinical officer. He resigned from that post in late November.
At THR, Varga will be responsible for integrating clinical enterprise, including quality, patient safety, and patient experience initiatives. He’ll also oversee physician relationships, clinical integration, care design, and clinical research, and education.
Doug Hawthorne, Texas Health Resources’ CEO, said the system conducted “an extensive national search” to fill the post, one that involved board members and independent physicians. “We knew we were looking for a unique individual,” Hawthorne said in a statement. “Dan Varga will accelerate the momentum on our clinical integration and physician-directed population health management activities, which are critical components in the next phase of our 10-year strategic focus. Advancing physicians in key leadership roles alongside operations leaders at all levels of the system brings together a depth of clinical and operational expertise that will help us understand and address all aspects of patient care. This approach will enable us to connect the dots along the care continuum—from wellness, prevention and primary care to acute care, rehabilitation and end-of-life care.”
Varga also will oversee the creation of new care models and new payment methods, Hawthorne said.
Prior to KentuckyOne, Varga held executive posts at Saint Joseph Health System in Lexington, Ky., SSM Healthcare-Saint Louis, and Norton Healthcare in Louisville. He also was founder and president of Community Medical Associates, a large primary care physician group. Board-certified in internal medicine, Varga earned his bachelor’s degree at the University of Kentucky and studied medicine at the University of Louisville.